The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Phase II Study of Maintenance With Azacitidine in MDS Patients
Official Title: A Phase II Study of Maintenance With Azacitidine in MDS Patients Achieving Complete or Partial Remission (CR or PR) After Intensive Chemotherapy
Study ID: NCT00446303
Brief Summary: A phase II multicentre trial of maintenance with Azacitidine in MDS patients achieving complete or partial remission (CR or PR) after intensive chemoterapy. The primary objective is response duration (MDS or AML)
Detailed Description: A academic multicentre study whose aims are to study the benefits of a maintenance therapy with 24 monthly courses af azacytidine in high-risk MDS patients, previously treated with intensive chemotherapy with obtention of a partial or complete response and not eligible for allogeneic transplantation
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
CHU d'Amiens, Amiens, , France
CHU Angers, Angers, , France
CH d'Avignon, Avignon, , France
CHU de Caen, Caen, , France
Hopital d'Instruction des Armées Percy, Clamart, , France
Hopital Henri Mondor, Creteil, , France
CHU de Dijon, Dijon, , France
CHU Albert Michallon, Grenoble, , France
CHRU Hurriez, Lille, , France
CHRU de Limoges, Limoges, , France
Hopital Edouard Herriot, Lyon, , France
Hopital Paoli Calmette, Marseille, , France
Hopital Hotel Dieu, Nantes, , France
Hopital Archet, Nice, , France
Hopital Saint Louis, Paris, , France
Hopital Saint Antoine, Paris, , France
Hopital Cochin, Paris, , France
Hopital Haut Leveque, Pessac, , France
Hopital Jean-Bernard, Poitiers, , France
CHRU de Reims, Reims, , France
CHU Pontchaillou, Rennes, , France
Hopital Hautepierre, Strasbourg, , France
Hopital Purpan, Toulouse, , France
CHU Brabois, Vandoeuvre, , France
CH Versailles, Versailles, , France
Name: Claude GARDIN, MD
Affiliation: Groupe Francophone des Myelodysplasies
Role: PRINCIPAL_INVESTIGATOR